Pemetrexed for the treatment of malignant pleural mesothelioma.

GUIDELINE TITLE
Pemetrexed for the treatment of malignant pleural mesothelioma.

BIBLIOGRAPHIC SOURCE(S)
National Institute for Health and Clinical Excellence (NICE). Pemetrexed for the treatment of malignant pleural mesothelioma. London (UK): National Institute for Health and Clinical Excellence (NICE); 2008 Jan. 28 p. (Technology appraisal guidance; no. 135).

GUIDELINE STATUS
This is the current release of the guideline.

abrir aquí para acceder al documento AHRQ NGC completo:
Pemetrexed for the treatment of malignant pleural mesothelioma.